• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体穿透活细胞:致病、预防及免疫治疗意义

Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications.

作者信息

Ruiz-Argüelles Alejandro, Rivadeneyra-Espinoza Liliana, Alarcón-Segovia Donato

机构信息

Department of Immunology, Laboratorios Clínicos de Puebla, México.

出版信息

Curr Pharm Des. 2003;9(23):1881-7. doi: 10.2174/1381612033454379.

DOI:10.2174/1381612033454379
PMID:12871192
Abstract

The dogmatic and at one time prevalent concept that intact antibody molecules were not able to enter into viable cells has now been modified due to the availability of a large amount of experimental findings and clinical observations that indicate otherwise. Penetration of mature autoantibodies into living cells might participate in the pathogenesis of diverse autoimmune diseases, through inducing apoptosis of healthy tissues and cells, but also by contributing to the breakdown of self-tolerance through presentation of self-antigens to the immune system. Conversely, the penetration of naturally occurring autoantibodies into immature lymphoid cells might have a physiological role in the edition of the immune repertoire in healthy individuals. Increasing interest is being paid to the potential immunotherapeutic role of penetrating antibodies as tools to deliver drugs, isotopes or genes into cells.

摘要

过去曾盛行的教条观念认为完整的抗体分子无法进入活细胞,如今这一观念已因大量实验结果和临床观察表明并非如此而得到修正。成熟自身抗体进入活细胞可能参与多种自身免疫性疾病的发病机制,既通过诱导健康组织和细胞凋亡,也通过将自身抗原呈递给免疫系统从而导致自身耐受性的破坏。相反,天然存在的自身抗体进入未成熟淋巴细胞可能在健康个体免疫库的编辑中具有生理作用。作为将药物、同位素或基因导入细胞的工具,穿透性抗体的潜在免疫治疗作用正受到越来越多的关注。

相似文献

1
Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications.抗体穿透活细胞:致病、预防及免疫治疗意义
Curr Pharm Des. 2003;9(23):1881-7. doi: 10.2174/1381612033454379.
2
Penetration of autoantibodies into living cells, 2000.
Isr Med Assoc J. 2001 Feb;3(2):121-6.
3
[One step towards restoration of self-tolerance in human autoimmune diseases].[迈向人类自身免疫性疾病自身耐受恢复的一步]
Med Sci (Paris). 2007 Feb;23(2):167-71. doi: 10.1051/medsci/2007232167.
4
Modified vaccination technique for prophylactic and therapeutic applications to combat endogenous antigen-induced disorders.改良疫苗接种技术在预防和治疗内源性抗原诱导疾病中的应用。
Scand J Immunol. 2010 Mar;71(3):125-33. doi: 10.1111/j.1365-3083.2009.02360.x.
5
The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by dysregulation and/or cell damage.自身抗体进入细胞可能通过自身反应性淋巴细胞凋亡诱导对自身的耐受,并通过调节异常和/或细胞损伤导致自身免疫性疾病。
J Autoimmun. 1996 Apr;9(2):295-300. doi: 10.1006/jaut.1996.0038.
6
Natural human antibodies to synthetic peptide autoantigens: correlations with age and autoimmune disease.针对合成肽自身抗原的天然人类抗体:与年龄及自身免疫性疾病的相关性
Gerontology. 1993;39(2):65-79. doi: 10.1159/000213517.
7
Immunopathological events initiated and maintained by pathogenic IgG autoantibodies in an experimental autoimmune kidney disease.致病性 IgG 自身抗体在实验性自身免疫性肾病中引发和维持的免疫病理事件。
Autoimmunity. 2012 Nov;45(7):495-509. doi: 10.3109/08916934.2012.702812. Epub 2012 Aug 17.
8
A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth.癌症患者和自身免疫性疾病患者存在一组共同的自身抗体:炎症在其诱导过程中的作用以及对肿瘤生长的影响。
Cancer Lett. 2009 Aug 18;281(1):8-23. doi: 10.1016/j.canlet.2008.11.009. Epub 2008 Dec 16.
9
Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity.系统性自身免疫性疾病中的自身抗体:特异性与致病性。
J Clin Invest. 2015 Jun;125(6):2194-202. doi: 10.1172/JCI78084. Epub 2015 May 4.
10
Definition of human autoimmunity--autoantibodies versus autoimmune disease.人类自身免疫的定义——自身抗体与自身免疫性疾病。
Autoimmun Rev. 2010 Mar;9(5):A259-66. doi: 10.1016/j.autrev.2009.12.002. Epub 2009 Dec 4.

引用本文的文献

1
Anti-mitochondrial antibodies in systemic sclerosis target enteric neurons and are associated with GI dysmotility.系统性硬化症中的抗线粒体抗体靶向肠神经元,并与胃肠动力障碍相关。
medRxiv. 2024 Nov 30:2024.11.26.24317983. doi: 10.1101/2024.11.26.24317983.
2
Clinical Significance of Uncommon, Non-Clinical, and Novel Autoantibodies.罕见、非临床及新型自身抗体的临床意义
Immunotargets Ther. 2024 Apr 25;13:215-234. doi: 10.2147/ITT.S450184. eCollection 2024.
3
Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions.
治疗性抗体的药代动力学和药效学建模:进展、挑战与未来方向
Pharmaceutics. 2021 Mar 21;13(3):422. doi: 10.3390/pharmaceutics13030422.
4
Antinuclear Autoantibodies in Health: Autoimmunity Is Not a Synonym of Autoimmune Disease.健康状态下的抗核自身抗体:自身免疫并非自身免疫性疾病的同义词。
Antibodies (Basel). 2021 Feb 25;10(1):9. doi: 10.3390/antib10010009.
5
Targeted Intracellular Delivery of Antibodies: The State of the Art.抗体的靶向细胞内递送:现状
Front Pharmacol. 2018 Oct 24;9:1208. doi: 10.3389/fphar.2018.01208. eCollection 2018.
6
Peptide Sharing Between Viruses and DLX Proteins: A Potential Cross-Reactivity Pathway to Neuropsychiatric Disorders.病毒与DLX蛋白之间的肽共享:通往神经精神疾病的潜在交叉反应途径。
Front Neurosci. 2018 Mar 21;12:150. doi: 10.3389/fnins.2018.00150. eCollection 2018.
7
Immunological evidence and regulatory potential for cell-penetrating antibodies in intravenous immunoglobulin.静脉注射用免疫球蛋白中穿透细胞抗体的免疫证据和调节潜力。
Clin Transl Immunology. 2015 Oct 2;4(10):e42. doi: 10.1038/cti.2015.18. eCollection 2015 Oct.
8
Immunophenotypic characterization of lymphoid cell infiltrates in vitiligo.白癜风中淋巴样细胞浸润的免疫表型特征。
Clin Exp Immunol. 2013 Aug;173(2):179-83. doi: 10.1111/cei.12096.
9
Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown.自身抗体与驻留肾细胞在狼疮性肾炎发病机制中的作用:探索未知
Clin Dev Immunol. 2012;2012:139365. doi: 10.1155/2012/139365. Epub 2012 Jun 14.
10
Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE.系统性红斑狼疮中致病性和偶发现象性抗DNA抗体
Autoimmune Dis. 2010 Jul 20;2011:462841. doi: 10.4061/2010/462841.